Podcast
MSL Talk: Tom Caravela, Eddie Power
Perceived, Probe, Reflect-KOL Engagement Model
Summary
In this episode, Tom Caravela is joined by Cto delve into her innovative KOL engagement model. Amy shares her career journey and introduces her perceive, probe, and reflect approach. The discussion covers the importance of pre-call planning, researching KOLs, and adapting to various personality types. Amy provides insights into effective probing techniques, setting up future engagements, and follow-up strategies. The conversation also addresses common mistakes made by MSLs and offers advice for overcoming challenges. The episode concludes with thoughts on the future of the MSL role and a reminder for listeners to subscribe and leave reviews.
My guest today is Amy Patel, Executive Medical Scientific Liaison, with Takeda Pharmaceuticals and she shares her KOL Engagement Model…Perceived, Probe, Reflect
Amy discusses…
👉 How she came up with “Perceived, Probe, Reflect”
👉 The importance of pre-calling plans for MSLs
👉 How MSLs should conduct research on their KOLs
👉 Her advice for MSLs on probing
👉 What MSLs need to take out of KOL meetings
👉 Recommendations for follow-ups
👉 Common mistakes with KOL engagement
KOL engagement model, MSL role evolution, pre-call planning strategies, effective probing techniques, common MSL mistakes
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Eddie Power
Podcast
MSL Talk: Tom Caravela, Sarah Snyder
The MSL - 4 Years, 200 Episodes…What’s new, What’s not
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Podcast
MSL Talk: Tom Caravela, Josh Corriveau
MSL Career Options: The transition from Field Medical to Medical Director
Article
Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
Article
Sarah A. Weiss, MD, and Harriet Kluger, MD